InvestorsHub Logo
Followers 23
Posts 3372
Boards Moderated 0
Alias Born 08/05/2019

Re: None

Friday, 07/31/2020 8:40:47 PM

Friday, July 31, 2020 8:40:47 PM

Post# of 1742
6/19/20 Evoke Pharma confirmed the FDA approved the New Drug Application for GIMOTI (metoclopramide) nasal spray, the first and only nasally-administered product indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis
Briefing.com 6/22/20 6:08 AM E

FDA Approves Evoke's GIMOTI(TM)
Dow Jones 6/19/20 3:32 PM ET
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News